查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466219

人類微生物組市場：按疾病、技術、產品、治療領域、應用分類 - 全球預測 2024-2030

Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人類微生物組市場規模預計為15.8億美元，預計2024年將達到19.6億美元，2030年將達到71.1億美元，複合年成長率為23.90%。

人類微生物組是存在於人體內的微生物基因組的集合。這包括細菌、古細菌、病毒和真核微生物。人體含有數兆個微生物細胞，影響身體功能和健康。幫助消化食物，抵抗病原體，並發展免疫系統。同時，慢性病盛行率的上升以及將微生物組與各種健康狀況聯繫起來的研究需求進一步推動了對基於微生物組的診斷和治療的需求。營養領域對微生物組的需求不斷成長，推動了對人類微生物組支持和影響整體健康和免疫功能的需求。然而，與活生物治療產品核准相關的監管障礙以及理解和操縱微生物組的複雜性給主要參與者帶來了重大挑戰。本公司繼續專注於研發 (R&D) 活動以及具有成本效益且易於使用的定序技術，以最佳化業務成長。此外，新治療劑開發的重大進展和投資增加正在為全球地區營運的主要企業創造重大機會。人工智慧 (AI) 和高級機器學習 (ML) 等開發的關鍵技術正在與微生物組研究相結合，以更好地了解複雜的微生物相互作用並開發新的治療解決方案。

主要市場統計
基準年[2023] 15.8億美元
預測年份 [2024] 19.6億美元
預測年份 [2030] 71.1億美元
複合年成長率（%） 23.90%

技術 16s rRNA定序和體學技術的最新進展使研究人體內的分子因素和過程成為可能

16s 核醣體 RNA定序是一種廣泛使用的技術，用於識別和比較樣本中的細菌。它重點關注 16S rRNA 基因，該基因是原核核醣體 30S 小次單元的組成部分，在不同物種的細菌和古細菌中高度保守。這項技術可以幫助研究人員對細菌進行分類並確定其譜系，從而深入了解微生物組的組成。另一方面，細胞培養技術涉及在受控條件下（通常在自然環境之外）培養細胞。在微生物組研究中，細胞培養技術使我們能夠分離和維持微生物以進行研究。包括次世代定序儀(NGS) 在內的高通量技術徹底改變了微生物群落研究的速度和規模。這些技術可以同時對數百萬個 DNA 分子進行定序，從而全面了解微生物組的多樣性和功能。此外，元基因組分析可以分析從環境樣本中獲得的遺傳物質，從而消除了研究人員在實驗室培養生物體的需要。這項技術對於研究人類微生物組很有用，因為它可以對所有存在的微生物的遺傳物質進行獨立於培養的檢查，甚至是那些不易在試管內生長的微生物。此外，基因組學、轉錄組學、蛋白質組學和代謝體學等體學技術提供了對生物系統的整體情況和高解析度見解。在微生物組研究中，這些技術詢問各種分子因素和過程，包括基因組 RNA 轉錄物、蛋白質體學和微生物群落的代謝物。

應用擴大人類微生物組在各種健康狀況的醫療保健診斷和治療中的應用

人類微生物組是存在於人體內部和表面的微生物基因組的集合，其在診斷方面的潛力是一個越來越受關注的領域。次世代定序儀和生物資訊學的進步使研究人員能夠將特定的微生物組成和活性與各種健康狀況聯繫起來。在診斷領域，分析人類微生物組有助於識別發炎性腸道疾病、糖尿病和某些癌症等疾病的生物標記。在治療領域，人類微生物群透過基於微生物群的療法提供了個人化醫療的潛力。糞便微生物移植（FMT）用於透過恢復健康的微生物平衡來治療困難梭狀芽孢桿菌傳染病。

區域洞察

在美洲，在先進的微生物組研發和商業化的推動下，美國和加拿大的人類微生物組經歷了顯著成長，許多公司積極致力於開發基於微生物組的治療方法和診斷方法。該地區的人類微生物組景觀正在穩步發展，研究重點是了解微生物組對人類健康和疾病的影響。同時，歐洲國家政府對微生物組研究展現了強力的支持，並建立了許多舉措和研究聯盟。歐洲的法律規範正在不斷發展，以支持微生物組資料和產品的安全和道德的使用。中東和非洲地區是人類微生物組產品不斷成長的市場，這主要是由於與文明病的增加和醫療保健支出的增加。同時，由於人們越來越認知到微生物平衡對整體健康的重要性、醫療保健成本不斷上升以及微生物基因組學的進步，亞太地區人類微生物組市場正在顯著成長。該地區益生菌、益生元和合合益素的研究和開發正在不斷發展，特別是為了解決胃腸道疾病和慢性病等當地健康問題。

FPNV定位矩陣

FPNV定位矩陣對於評估人類微生物組市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對人類微生物組市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 人類微生物組市場的市場規模與預測是多少？

2.在人類微生物組市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.人類微生物組市場的技術趨勢和法規結構是什麼？

4.人類微生物組市場主要廠商的市場佔有率是多少？

5. 進入人類微生物組市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 專注於開發人類微生物組療法
      • 用於藥物發現、早期疾病檢測和診斷的人類微生物組
      • 益生菌和嬰兒營養中微生物組的需求增加
    • 抑制因素
      • 缺乏微生物組治療的專業知識和安全問題
    • 機會
      • 增加合作和研究投資以創造成長機會
      • 新治療藥物的開發
    • 任務
      • 了解細菌種類數量的限制以及基於人類微生物組的藥物的不確定性
  • 市場區隔分析
    • 技術：16s rRNA定序和體學技術的最新進展，用於研究人體分子因素和過程
    • 應用：人類微生物組在醫療保健診斷和治療中的應用越來越多，以解決各種健康狀況。
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化
    • 智慧財產權情況

第6章人類微生物組市場：依疾病分類

  • 急性腹瀉
  • 自體免疫疾病
  • 癌症
  • 糖尿病
  • 精神障礙
  • 肥胖

第7章人類微生物組市場：依技術分類

  • 16s rRNA定序
  • 細胞培養技術
  • 計算工具
  • 高通量技術
  • 元基因組定序
  • 體學技術

第8章人類微生物組市場：依產品

  • 診斷設備
  • 藥物
  • 食品
  • 益生元和益生菌

第 9 章按治療領域分類的人類微生物組市場

  • 胃腸道疾病
  • 代謝紊亂
  • 皮膚病
  • 女性健康

第10章人類微生物組市場：依應用分類

  • 診斷
  • 治療藥物

第11章美洲人類微生物組市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區人類微生物組市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲人類微生物組市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 臨床微生物組學宣布與 CosmosID 合併
    • 雀巢與 APC Microbiome 合作開發健康與福祉產品
    • 華盛頓大學醫學院建立新的微生物體研究中心

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-430D42AA0FCD

[198 Pages Report] The Human Microbiome Market size was estimated at USD 1.58 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 23.90% to reach USD 7.11 billion by 2030.

The human microbiome is the collective genomes of the microorganisms that reside on and inside the human body. These include bacteria, archaea, viruses, and eukaryotic microbes. The human body hosts trillions of these microbial cells, which can influence bodily functions and health. It assists in the digestion of food, protection against pathogens, and the development of the immune system. Meanwhile, the rise in chronic disease prevalence and a growing need for research linking the microbiome to various health conditions further stokes demand for microbiome-based diagnostics and therapeutics. The growing need for a microbiome in nutrition propels the demand for a human microbiome to support and influence overall wellness and immune function. However, the regulatory hurdles associated with approving live biotherapeutic products and complexities in comprehending and manipulating the microbiome present a significant challenge for the key players. Companies are continuously focusing on research and development (R&D) activities and cost-effective and accessible sequencing technologies to optimize their business growth. Moreover, the advancements in developing novel human microbiome therapeutics and rising investments present a significant opportunity for the key companies operating in the global space. Emerging technologies such as artificial intelligence (AI) and advanced machine learning (ML) are integrated with microbiome research to understand complex microbial interactions better and develop novel therapeutic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.58 billion
Estimated Year [2024] USD 1.96 billion
Forecast Year [2030] USD 7.11 billion
CAGR (%) 23.90%

Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body

16s ribosomal RNA sequencing is a widely used method for identifying and comparing bacteria within a sample. It focuses on the 16S rRNA gene, a component of the 30S small subunit of prokaryotic ribosomes, which is highly conserved within different species of bacteria and archaea. This technique helps researchers classify and determine the phylogeny of bacteria, providing insights into the microbiome's composition. On the other hand, cell culture technology involves growing cells under controlled conditions, typically outside their natural environment. In microbiome research, cell culture technology allows scientists to isolate and maintain microorganisms for study. High-throughput technologies, including next-generation sequencing (NGS), have revolutionized the speed and scale at which microbial communities can be studied. These methods allow for the simultaneous sequencing of millions of DNA molecules, offering a comprehensive view of the microbiome's diversity and function. Moreover, metagenomic sequencing analyzes the genetic material obtained from environmental samples, helping researchers bypass the need to cultivate organisms in the lab. This technology helps study the human microbiome by allowing for a culture-independent examination of the genetic material of all microorganisms present, including those not easily cultured in vitro. Furthermore, omics technologies, such as genomics, transcriptomics, proteomics, and metabolomics, provide holistic views and high-resolution insights into biological systems. In microbiome research, these technologies investigate various molecular factors and processes, such as the genomics RNA transcripts, proteomics, and metabolites of microbial communities.

Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions

The human microbiome, comprised of the collective genome of microorganisms residing in and on the human body, has become an area of increasing interest for its potential in diagnostics. Advancements in next-generation sequencing and bioinformatics have allowed researchers to correlate specific microbial compositions and activities with various health conditions. For diagnostics, analysis of the human microbiome facilitates the identification of biomarkers for diseases such as inflammatory bowel disease, diabetes, and certain types of cancer. In the therapeutic domain, the human microbiome offers the potential for personalized medicine through microbiota-based treatments. Fecal microbiota transplantation (FMT) is used to treat clostridium difficile infections by restoring a healthy microbial balance.

Regional Insights

In the Americas, the United States and Canada witnessed significant growth in human microbiome driven by the research and commercialization of advanced microbiome, with numerous companies actively engaged in developing microbiome-based therapies and diagnostics. The human microbiome landscape in this region is steadily growing, focusing on research aimed at understanding the impact of the microbiome on human health and disease. On the other hand, European countries exhibit strong government support for microbiome research with numerous initiatives and research consortia in place. The regulatory framework in Europe is evolving to support the safe and ethical use of microbiome data and products. The Middle East and Africa region represents a growing market for human microbiome products, primarily driven by an increasing burden of lifestyle diseases and growing healthcare expenditure. At the same time, the human microbiome landscape in the Asia-Pacific region is experiencing significant growth, driven by increasing awareness of the importance of microbial balance to overall health, rising healthcare expenditures, and advancements in microbial genomics. Research and development in probiotics, prebiotics, and symbiotics are growing in this region, particularly in addressing regional health issues such as gastrointestinal disorders and chronic diseases.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Microbiome Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Microbiome Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Microbiome Market, highlighting leading vendors and their innovative profiles. These include AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., Azitra, BiomeSense, Inc., BiomX Ltd., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Illumina, Inc., Intralytix, Inc., Invivo Healthcare, Locus Biosciences, Inc., Merck KGaA, Metabiomics Corporation, Osel Inc., Rebiotix Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome Life Sciences, Inc., and Yakult Honsha Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Microbiome Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease
    • Acute Diarrhea
    • Autoimmune Disorders
    • Cancer
    • Diabetes
    • Mental Disorders
    • Obesity
  • Technology
    • 16s rRNA Sequencing
    • Cell Culture Technology
    • Computational Tools
    • High-Throughput Technology
    • Metagenomic Sequencing
    • Omics Technology
  • Product
    • Diagnostic Devices
    • Drugs
    • Foods
    • Prebiotic & Probiotics
  • Therapeutic Area
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Skin Disorders
    • Women's Health
  • Application
    • Diagnostics
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Microbiome Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Microbiome Market?

3. What are the technology trends and regulatory frameworks in the Human Microbiome Market?

4. What is the market share of the leading vendors in the Human Microbiome Market?

5. Which modes and strategic moves are suitable for entering the Human Microbiome Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
      • 5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
      • 5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
      • 5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
    • 5.2.2. Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization
    • 5.9.1. Intellectual Property Landscape

6. Human Microbiome Market, by Disease

  • 6.1. Introduction
  • 6.2. Acute Diarrhea
  • 6.3. Autoimmune Disorders
  • 6.4. Cancer
  • 6.5. Diabetes
  • 6.6. Mental Disorders
  • 6.7. Obesity

7. Human Microbiome Market, by Technology

  • 7.1. Introduction
  • 7.2. 16s rRNA Sequencing
  • 7.3. Cell Culture Technology
  • 7.4. Computational Tools
  • 7.5. High-Throughput Technology
  • 7.6. Metagenomic Sequencing
  • 7.7. Omics Technology

8. Human Microbiome Market, by Product

  • 8.1. Introduction
  • 8.2. Diagnostic Devices
  • 8.3. Drugs
  • 8.4. Foods
  • 8.5. Prebiotic & Probiotics

9. Human Microbiome Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Gastrointestinal Disorders
  • 9.3. Metabolic Disorders
  • 9.4. Skin Disorders
  • 9.5. Women's Health

10. Human Microbiome Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnostics
  • 10.3. Therapeutics

11. Americas Human Microbiome Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Human Microbiome Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Human Microbiome Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Clinical Microbiomics Announces Merger with CosmosID
    • 14.3.2. Nestle Partners APC Microbiome on Health and Wellbeing Products
    • 14.3.3. UW Medicine Launches a New Center to Study Microbiomes

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HUMAN MICROBIOME MARKET DYNAMICS
  • FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 287. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 297. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 307. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 317. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 327. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 331. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 336. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 337. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 340. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 341. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 342. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 343. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 346. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 347. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 350. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 351. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 352. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 353. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 356. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 357. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 360. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 361. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 362. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TEC